Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination

Individuals infected with the human immunodeficiency virus type 1 (HIV-1) belong to the group of people most vulnerable to SARS-CoV-2 infections and the associated disease COVID-19. Here we describe SARS-CoV-2-specific antibody and cellular immune responses in a small cohort of immunological non-res...

Descripción completa

Detalles Bibliográficos
Autores principales: Sisteré-Oró, Marta, Andrade, Naina, Wortmann, Diana D.J., Du, Juan, Garcia-Giralt, Natalia, González-Cao, María, Güerri-Fernández, Robert, Meyerhans, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459333/
https://www.ncbi.nlm.nih.gov/pubmed/36091014
http://dx.doi.org/10.3389/fimmu.2022.994173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459333/
https://www.ncbi.nlm.nih.gov/pubmed/36091014
http://dx.doi.org/10.3389/fimmu.2022.994173

Ejemplares similares